Decoy Therapeutics Inc. Insider Trading
DCOY
Insiders sold $17 and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Nov 2025.
Get an email when DCOY's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Arnold C Hanish Director | SoldNo plan 2 parts | 27 | $0.64 average | $17 | 0.5% | Form 4 |
| Nov 20, 2025 | Arnold C Hanish Director | Bought | 5,000 | $0.75 | 4K | 18519% | Form 4 |
| Nov 20, 2025 | Mark J Rosenblum Exec VP Finance, CFO | Bought | 20,000 | $0.80 | 16K | 11299% | Form 4 |
- Dec 30, 2025No planArnold C HanishDirector · sold 27 at avg $0.64$170.5% of stake
- Nov 20, 2025Arnold C HanishDirector · bought 5,000 at $0.754K18519% of stake
- Nov 20, 2025Mark J RosenblumExec VP Finance, CFO · bought 20,000 at $0.8016K11299% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with DCOY
Held by ETFs
DCOY is in 1 US ETF. The largest of them, with DCOY's weight in each:
Spot a number that looks wrong? Check it in DCOY's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing DCOY
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.